COVID-19 vaccination program in Cambodia: Achievements and remaining challenges.

IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Global health & medicine Pub Date : 2023-04-30 DOI:10.35772/ghm.2023.01002
Ikuma Nozaki, Masahiko Hachiya, Chieko Ikeda
{"title":"COVID-19 vaccination program in Cambodia: Achievements and remaining challenges.","authors":"Ikuma Nozaki,&nbsp;Masahiko Hachiya,&nbsp;Chieko Ikeda","doi":"10.35772/ghm.2023.01002","DOIUrl":null,"url":null,"abstract":"<p><p>Since Cambodia has been recognized as one of the low- and middle-income countries with a successful COVID-19 vaccine program, its program approaches were reviewed based mainly on press articles and announcements from the Ministry of Health. From the beginning, the government's proactive approach to securing vaccines and its flexibility prior to WHO Emergency Use Listing (EUL) contributed greatly to the success of the program. Vaccines were provided by COVAX and other countries, but more than half of the vaccines secured were Chinese vaccines purchased with government funds. The rollout of the vaccine has also been flexible, moving from a strategy of prioritizing risk groups and essential workers to one of expanding the campaign from population centers to rural areas, as well as gradually expanding the target age group, eventually targeting the population age 3 and older. As a result of this high level of commitment by the government and its flexible response, Cambodia has achieved 95% primary series coverage of the entire population, including those not eligible for vaccination. Although the sixth booster is now being administered in Cambodia and vaccination every six months was recommended, several challenges might be anticipated in continuing this program, including the lack of clear global guidance on how to sustain and modify the COVID-19 immunization program and vaccine fatigue after COVID-19 outbreaks have been controlled. How these challenges are overcome and how the COVID-19 vaccine program remains need to be carefully observed into the future.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"5 2","pages":"92-98"},"PeriodicalIF":1.9000,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130549/pdf/ghm-5-2-92.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global health & medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35772/ghm.2023.01002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 1

Abstract

Since Cambodia has been recognized as one of the low- and middle-income countries with a successful COVID-19 vaccine program, its program approaches were reviewed based mainly on press articles and announcements from the Ministry of Health. From the beginning, the government's proactive approach to securing vaccines and its flexibility prior to WHO Emergency Use Listing (EUL) contributed greatly to the success of the program. Vaccines were provided by COVAX and other countries, but more than half of the vaccines secured were Chinese vaccines purchased with government funds. The rollout of the vaccine has also been flexible, moving from a strategy of prioritizing risk groups and essential workers to one of expanding the campaign from population centers to rural areas, as well as gradually expanding the target age group, eventually targeting the population age 3 and older. As a result of this high level of commitment by the government and its flexible response, Cambodia has achieved 95% primary series coverage of the entire population, including those not eligible for vaccination. Although the sixth booster is now being administered in Cambodia and vaccination every six months was recommended, several challenges might be anticipated in continuing this program, including the lack of clear global guidance on how to sustain and modify the COVID-19 immunization program and vaccine fatigue after COVID-19 outbreaks have been controlled. How these challenges are overcome and how the COVID-19 vaccine program remains need to be carefully observed into the future.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
柬埔寨COVID-19疫苗接种规划:成就和仍然存在的挑战
由于柬埔寨被公认为成功实施COVID-19疫苗规划的低收入和中等收入国家之一,因此主要根据新闻文章和卫生部的公告对其规划方法进行了审查。从一开始,政府为确保疫苗而采取的积极措施及其在世卫组织紧急用途清单(EUL)之前的灵活性为该规划的成功做出了巨大贡献。疫苗由COVAX和其他国家提供,但超过一半的疫苗是用政府资金购买的中国疫苗。疫苗的推广也很灵活,从优先考虑危险群体和关键工作人员的战略,转变为将运动从人口中心扩大到农村地区的战略,并逐步扩大目标年龄组,最终以3岁及以上人口为目标。由于政府的这种高度承诺及其灵活的应对措施,柬埔寨实现了95%的初级系列接种覆盖率,包括那些没有资格接种疫苗的人。虽然目前正在柬埔寨接种第六剂加强剂,并建议每六个月接种一次疫苗,但预计继续实施该计划可能会面临一些挑战,包括缺乏关于如何维持和修改COVID-19免疫规划的明确全球指导,以及在COVID-19疫情得到控制后疫苗疲劳。未来需要仔细观察如何克服这些挑战以及COVID-19疫苗规划如何继续下去。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
7.70%
发文量
0
期刊最新文献
Advances in HIV management and challenges in Japan: Current situation of pre-exposure prophylaxis in Tokyo. Analysis of tumor infiltrating immune cells in Kaposi sarcoma lesions discovers shifts in macrophage populations. Changes in epidemiological and treatment-related characteristics among newly reported HIV/AIDS cases in an urban area in Shanghai, China from 2001 to 2019: A population-based retrospective study. Exploration of PrEP/PEP service delivery model in China: A pilot in eastern, central and western region. Identification of new circulating recombinant form of HIV-1 CRF139_02B in Japan, and search for the origin.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1